 |
 |
|
|
News for Food and Drug Administration (FDA)News > FDAListings 321 - 330 of 441:
Shelhigh Responds to FDA Allegations
FDA investigators and U.S. Marshals recently seized all implantable medical devices from Shelhigh, Inc. after FDA inspectors claimed significant defic...
Boston Scientific Announces FDA Approval of Innovative Heart Failure Lead
Boston Scientific Corporation announced U.S. Food and Drug Administration (FDA) approval of the ACUITY(R) Steerable left ventricular lead for use with...
FDA Accepts GPC Biotech's Satraplatin NDA for Filing and Grants Priority Review Status
GPC Biotech AG announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company’s New Drug Application (NDA) for satrapl...
FDA Announces Recommendations to Reauthorize Medical Device User Fee Program
The U.S. Food and Drug Administration (FDA) proposed recommendations to Congress for reauthorizing the Medical Device User Fee and Modernization Act (...
FDA Licenses First U.S. Vaccine For Humans Against Avian Influenza
Sanofi pasteur, the vaccines division of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has licensed its H...
FDA Seizes All Medical Products From N.J. Device Manufacturer for Significant Manufacturing Violations
U.S. Food and Drug Administration (FDA) investigators and U.S. Marshals seized all implantable medical devices from Shelhigh, Inc., Union, N.J., after...
FDA Warns Consumers about Health Risks of Potentially Contaminated Olives
The U.S. Food and Drug Administration (FDA) is alerting consumers to possible serious health risks from eating olives that may be contaminated with a ...
FDA Announces Recommendations to Reauthorize Medical Device User Fee Program
The U.S. Food and Drug Administration (FDA) proposed recommendations to Congress for reauthorizing the Medical Device User Fee and Modernization Act (...
FDA Accepts GPC Biotech's Satraplatin NDA for Filing and Grants Priority Review Status
GPC Biotech AG announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's New Drug Application (NDA) for satrapl...
Lupin Receives US FDA Approval for Novel Formulation of Suprax Suspension
Lupin Pharmaceuticals announced that the U.S. Food and Drug Administration (US FDA) has approved the company's application for Suprax (Cefixime for ... |
|
RSS Feeds|
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home Copyright © 2007-2008 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved. |
 |
 |